Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol pretreatment to reduce etomidate-induced myoclonus
ChiCTR-PPD-16009008Phase 4Recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tramadol in myoclonus (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: myoclonus classification. Started Apr 2016; status: recruiting.
02
Drugs
tramadol
03
Conditions
myoclonus
Beyond the preview
Go deeper on ChiCTR-PPD-16009008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PPD-16009008.